Drug intelligence / Profile preview

Zn0.4Fe2.6O4-COOH

Development stage: Preclinical
Modality: Nanoparticles → Drug Delivery Systems
Administration: Intravenous

Overview

Zn0.4Fe2.6O4-COOH is a surface-modified ultrasmall zinc ferrite nanoparticle designed as a T1 contrast agent for magnetic resonance imaging (MRI). It is specifically tailored with a carboxylic acid (-COOH) surface coating to influence its charge and affinity, aiming to enhance the visualization of macrophages within atherosclerotic plaques, a key aspect in the progression and destabilization of atherosclerosis.

Beyond the preview

Go deeper on Zn0.4Fe2.6O4-COOH.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zn0.4Fe2.6O4-COOH.

Explore the full profile